RadioMedix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.radiomedix.com
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Radiomedix, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT05153772
- Locations
- 🇺🇸
Rocky Mountain Cancer Center, Denver, Colorado, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, United States
Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2022-12-22
- Lead Sponsor
- Radiomedix, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT03673943
- Locations
- 🇺🇸
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, United States
Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET
- First Posted Date
- 2018-03-15
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Radiomedix, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT03466216
- Locations
- 🇺🇸
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath